Jody Lynn Baron, MD, PhD

Swarthmore College, Swarthmore, PA, 1984-85 Rice University, Houston, Texas, BA, 1986, Biology & Philosophy
Yale University, MD 1993, Medicine
Yale University, PhD, 1994, Immunobiology
Stanford University, Residency, 1993-95 Internal Medicine
University of California, San Francisco, Clinical Fellow, 1995-96, Infectious Diseases
University of California, San Francisco, Fellowship, 1996-2000, Microbiol & Immunology

• 2000- 2002
  Assistant Research Scientist Departments of Microbiology and Immunology, and Internal Medicine, University of California, San Francisco
• 2003-2
  Assistant Professor of Medicine Department of Medicine, Divisions of Infectious Diseases & Gastroenterology (UCSF Liver Center), University of California, San Francisco

• 1982
  Westinghouse Science Talent Search honors group
• 1992
  NIH Resident research award
• 1986-1992
  NIH Fellowship -Medical Scientist Training Program Yale University
• 1992
  Molecular Medicine Fellowship, University of California at San Francisco
• 1997-2002
  Howard Hughes Postdoctoral Research Fellowship for Physicians
• 1992
  UCSF Liver center pilot research grant
• 2000-2002
  Pfizer Postdoctoral Fellowship in Infectious Diseases
• 2003-2002
  Burroughs Wellcome Career Award in the Biomedical Sciences
• 2002
  HHMI/BWF Leadership Coaching Award
• 2002
  American Gastroenterological Association Fiterman Basic Science Award
• 2004-2002
  American Liver Foundation Liver Scholar Award
• 2005-2002
  Cancer Research Institute Investigator award
• 2006-2011
  Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease
• 2011-2013
  UCSF Program in Breakthrough Biomedical Research Award

• 1. Chen, Youhai.; Kuchroo,V.K.; Inobe, J., Baron, J.; Janeway, C.J.; and Weiner, H.L. 1995. Oral Tolerance in Myelin basic Protein T cell Receptor Transgenic Mice: Induction of Encephalitogenic or Regulatory Cells is Dependent on Dose and Route of Antigen Exposure. PNAS ,93(1):388-91.
• 2. Grewal I.S.; Foellmer, H.G.; Grewal K.D.; Xu J, Hardardottir F; Baron J.L.; Janeway, C.A. Jr; Flavell R.A. 1996. Requirement for the CD40 Ligand in Costimulation Induction, T cell Activation, and Experimental Allergic Encephalomyelitis. Science, 273 (5283): 1864-7.
• 3. Romanic, Anne M.; Graesser, Donnasue, Baron, Jody L., Visintin, Irene, Janeway, Charles, Jr.; Madri, Joseph A. 1997. T Cell Adhesion to Endothelial Cells and Extracellular Matrix is Modulated upon Transendothelial Cell Migration. Laboratory Investigation, 76 (1): 11-23
• 4. LaFaille, Juan J.; Van de Keere, Fabienne; Baron, Jody L.; Haas, Werner; Raine, CS; and Tonegawa, Susumu. 1997. Myelin Basic Protein-specific Th-2 Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect them From Disease. Journal of Experimental Medicine, 186 (2):307-12.
• 5. 1Cerwenka, Adelheid, Jody L. Baron, Lewis L. Lanier. 2001. Ectopic Expression of Retinoic Acid Early Inducible-1 gene (RAE-1) Permits NK Cell-mediated Rejection of a MHC Class I-bearing Tumor . Proceedings of the National Academy of Science, 98 (20): 11521-6.
• 6. 1Baron, Jody L.; Gardiner, Leon,; Nishimura, Stephen; Locksley, Richard; and Ganem, Don. 2002. Activation of a non-classical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity, Vol 16 (4): 583-594.
• 7. Dezhi Mu, Stephanie Cambier, Lars Fjellbirkeland, Jody L. Baron, John S. Munger, Hisaaki Kawakatsu ,Dean Sheppard, V. Courtney Broaddus, Stephen L. Nishimura. 2002. The integrin avb8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-b 1. Journal of Cell Biology, Vol 157(3):493-507 .
• 8. 1Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, Mohrs M, Locksley RM, Kronenberg M. 2003. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci U S A, Jul 8;100(14):8395-400.
• 9. Stetson, Dan B., Marcus Mohrs, Lee. Reinhardt, Jody L. Baron, Zhi-En Wang, Laurent Gapin, Mitchell Kronenberg, and Richard M. Locksley. 2003. Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T cells Poised for Rapid Effector Function. J. Exp. Med.,198 (7):1069-1076.
• 10. Villarinho, Silvia, Kouetsu Ogasawara, Lewis Lanier, Stephen Nishimura, and Jody L. Baron. 2007. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to Hepatitis B Virus. Proceedings of the National Academy of Science, 104 (46): 18187-92.
• 11. Pubicover, Jean, Amanda Goodsell, Stephen Nishimura, Silvia Villarinho, ZE Wang, Lia Avanesyan, Rosanne Spolski,Warren Leonard, Stewart Cooper and Jody L Baron. 2011. Il-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. Journal of Clinical Investigation, March 1, 121(3): 1154-1162.
• 12. One page Research Highlight of above article in Nature Reviews Clinical Sciences- Gastroenterology and hepatology: May 2011 One page Research Highlight of above article in Nature Reviews Immunology: April 2011
• 13. Hideya Kitamura, Stephanie Cambier, Sangeeta Somanath, Tyren Barker, Shunsuke Minagawa, Jennifer Markovics, Amanda Goodsell, Jean Publicover, Benoit De Crombrugghe, Louis Reichardt, David Jablons, Paul Wolters, Arthur Hill, James D. Marks, Jianlong Lou, Jean Francois Pittet, Jack Gauldie, Jody L. Baron* , Stephen L. Nishimura* .. 2011. Lung fibroblasts regulate dendritic cell trafficking, airway inflammation and fibrosis, in vivo, through integrin avb8-mediated activation of TGF-b. * co-senior authors. Journal of Clinical Investigation, July 1, 121(7): 2863–2875.